Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil Indian pharma companies like Dr Reddy’s, Zydus, Cipla, and Sun can sustain low double-digit ...
Some results have been hidden because they may be inaccessible to you